biostudies-literatureUnknown67 Suppl 1Schlumberger MThe recent availability of molecular targeted therapies leads to a reconsideration of the treatment strategy for patients with distant metastases from medullary thyroid carcinoma. In patients with progressive disease, treatment with kinase inhibitors should be offered.Clinics (Sao Paulo, Brazil)125-9https://www.ebi.ac.uk/biostudies/studies/S-EPMC3328820biostudies-literatureKinase inhibitors for advanced medullary thyroid carcinoma.PMC3328820Leboulleux SSchlumberger MChougnet CMassicotte MHBaudin ENascimento CLfalseKinase inhibitors for advanced medullary thyroid carcinoma.The recent availability of molecular targeted therapies leads to a reconsideration of the treatment strategy for patients with distant metastases from medullary thyroid carcinoma. In patients with progressive disease, treatment with kinase inhibitors should be offered.2012-01-01T00:00:00Z20122024-11-13T07:44:30.471Z2019-03-27T00:52:26ZS-EPMC33288202258471710.6061/clinics/2012(sup01)21